$Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain$

Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain

Josep Maria Ribera Santasusana,1 Alejandra de Andrés Saldaña,2 Nuria García-Muñoz,3 Joana Gostkorzewicz,2 Diana Martínez Llinàs,3 Cristina Díaz de Heredia4 1Clinical Hematology Department, Catalan Institute of Oncology - Ho...

Full description

Bibliographic Details
Main Authors:	Ribera Santasusana JM, de Andrés Saldaña A, García-Muñoz N, Gostkorzewicz J, Martínez Llinàs D, Díaz de Heredia C
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-05-01
Series:	ClinicoEconomics and Outcomes Research
Subjects:	all cost-effectiveness tisagenlecleucel acute lymphoblastic leukaemia spain car-t
Online Access:	https://www.dovepress.com/cost-effectiveness-analysis-of-tisagenlecleucel-in-the-treatment-of-re-peer-reviewed-article-CEOR

Similar Items

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
by: Vairy S, et al.
Published: (2018-11-01)

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
by: Forsberg MH, et al.
Published: (2018-09-01)

Editor's Pick: The Role and Regulation of Quiescence in Acute Lymphoblastic Leukaemia
by: Robin Williams, et al.
Published: (2017-08-01)

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia
by: David Pesántez, et al.
Published: (2017-08-01)

The Role of Allograft in Acute Lymphoblastic Leukaemia, Including Alternate Donors
by: Julian Cooney
Published: (2017-08-01)

A retrospective study of acute lymphoblastic leukaemia in Paediatric patients at Dr George Mukhari Hospital (2003-2007)
by: Swanepoel, Yolande
Published: (2010)

Patients in Focus: What's Relevant for Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia?
by: Michele Baccarani, et al.
Published: (2017-08-01)

Targeted Therapy in Acute Lymphoblastic Leukaemia
by: Ross Salvaris, et al.
Published: (2021-07-01)

Efficacy and Safety of Axicabtagene Ciloleucel and Tisagenlecleucel Administration in Lymphoma Patients With Secondary CNS Involvement: A Systematic Review
by: XiaoQin Wu, et al.
Published: (2021-07-01)

Hyperoeosinophilia at diagnosis in adolescent acute lymphoblastic leukaemia/lymphoma: A case report and review of the literature
by: Dilshad Jahan, et al.
Published: (2020-01-01)

Papilledema in a child with Acute Lymphoblastic Leukaemia during remission-A Case Report
by: C Vivek Nandini Reddy, et al.
Published: (2020-01-01)

REMISSION RATE OF PRE-B ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) AFTER INDUCTION CHEMOTHERAPY FOLLOWING UNITED KINGDOM ACUTE LYMPHOBLASTIC LEUKAEMIA 2011 (UKALL 2011) TRIAL PROTOCOL
by: Hafiz Muhammad Murtaza, et al.
Published: (2021-04-01)

Hypereosinophilia: A rare presentation of acute lymphoblastic leukaemia
by: G Narayanan, et al.
Published: (2018-01-01)

CURRENT MANAGEMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA: EMERGING INSIGHTS AND OUTSTANDING QUESTIONS
by: Xavier Thomas, et al.
Published: (2016-07-01)

Aggressive lung involvement in a patient with T‐acute lymphoblastic leukaemia/lymphoblastic lymphoma: a tricky and rare case report
by: Chika Miyaoka, et al.
Published: (2020-08-01)

Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia
by: Shannon Cope, et al.
Published: (2019-09-01)

Allergic complications of L-asparaginase therapy in children with acute lymphoblastic leukaemia
by: Konstantinidis Georgios, et al.
Published: (2011-01-01)

Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR
by: Anita Badbaran, et al.
Published: (2020-07-01)

Importance of genotyping of Thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy
by: Dokmanović Lidija, et al.
Published: (2008-01-01)

B-Cell Acute Lymphoblastic Leukaemia of the Uterus
by: Eva Vanheule, et al.
Published: (2020-11-01)

Outcome of Childhood Acute Lymphoblastic Leukaemia after Induction Therapy --- Three-Year Experience in a Tertiary Care Hospital in Bangladesh
by: M Belayet Hossain, et al.
Published: (2017-01-01)

The use of biomarkers in detecting subclinical cardiotoxicity in doxorubicin-based treatment for paediatric patients with acute lymphoblastic leukaemia
by: Radu Letiția Elena, et al.
Published: (2017-04-01)

The clinical significance of current laboratory and other prognostic indicators in the management of South African children with Precursor B cell acute lymphoblastic leukaemia
by: Schapkaitz, Elise
Published: (2009)

Incidence, socioeconomic deprivation, volume-outcome and survival in adult patients with acute lymphoblastic leukaemia in England
by: Ravi Maheswaran, et al.
Published: (2018-01-01)

CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas
by: Aamir Ahmad, et al.
Published: (2020-05-01)

T-cell acute lymphoblastic leukaemia, mild leucocytosis causes severe tumour lysis syndrome
by: Dilshad Jahan, et al.
Published: (2019-01-01)

Preventive Healthcare and Management for Acute Lymphoblastic Leukaemia in Adults: Case Report and Literature Review
by: Wei-Ping Chen, et al.
Published: (2021-05-01)

Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton
by: Suzanne M. Johnson, et al.
Published: (2017-12-01)

High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia
by: Salvador Chulián, et al.
Published: (2021-12-01)

Frequency of the minor BCR-ABL (e1;a2) transcript oncogene in a Mexican population with adult acute lymphoblastic leukaemia
by: I. Olarte-Carrillo, et al.
Published: (2015-07-01)

Immunoglobulin genes and T-cell receptors as molecular markers in children with acute lymphoblastic leukaemia
by: Lazić Jelena, et al.
Published: (2009-01-01)

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia
by: Bree Foley, et al.
Published: (2020-01-01)

Natural Killer Cell Lymphoblastic Leukaemia/Lymphoma: Case Report and Review of the Recent Literature
by: Qanita Sedick, et al.
Published: (2017-07-01)

Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia
by: Qingsheng Huang, et al.
Published: (2021-06-01)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
by: Concetta Rafaniello, et al.
Published: (2020-09-01)

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
by: Guoqing Wei, et al.
Published: (2017-04-01)

Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
by: Kotnik Barbara Faganel, et al.
Published: (2017-09-01)

Acute Lymphoblastic Leukaemia Cells Impair Dendritic Cell and Macrophage Differentiation: Role of BMP4
by: Jaris Valencia, et al.
Published: (2019-07-01)

Precursor B- cell lymphoblastic lymphoma/leukaemia masquerading as epidermal cyst of scalp
by: Basab Bagchi, et al.
Published: (2020-09-01)

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: A Pediatric Real World CAR Consortium Report
by: Baggott, C., et al.
Published: (2022)